Factors Associated with Revision Surgery after Internal Fixation of Hip Fractures

Background: Femoral neck fractures are associated with high rates of revision surgery after management with internal fixation. Using data from the Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) trial evaluating methods of internal fixation in patients with femoral neck fractures, we investigated associations between baseline and surgical factors and the need for revision surgery to promote healing, relieve pain, treat infection or improve function over 24 months postsurgery. Additionally, we investigated factors associated with (1) hardware removal and (2) implant exchange from cancellous screws (CS) or sliding hip screw (SHS) to total hip arthroplasty, hemiarthroplasty, or another internal fixation device. Methods: We identified 15 potential factors a priori that may be associated with revision surgery, 7 with hardware removal, and 14 with implant exchange. We used multivariable Cox proportional hazards analyses in our investigation. Results: Factors associated with increased risk of revision surgery included: female sex, [hazard ratio (HR) 1.79, 95% confidence interval (CI) 1.25-2.50; P = 0.001], higher body mass index (fo

[Poly(ethylene terephthalate) Ionomer]/Silicate Hybrid Materials via Polymer-in situ Sol-Gel Reactions

A scheme was developed for producing poly(ethylene terephthalate (PET) ionomer)/silicate hybrid materials via polymer-in situ sol-gel reactions for tetraethylorthosilicate (TEOS) using different solvents. Scanning electron microscopy/EDAX studies revealed that silicate structures existed deep within PET ionomer films that were melt pressed from silicate-incorporated resin pellets. Si-29 solid-state NMR spectroscopy revealed considerable Si-O-Si bond formation, but also a significant fraction of SiOH groups. Na-23 solid-state NMR spectra suggested the presence of ionic aggregates within the unfilled PET ionomer, and that these aggregates do not suffer major structural rearrangements by silicate incorporation. For an ionomer treated with TEOS using MeCl2, Na+ ions are less associated with each other than in the unfilled control, suggesting silicate intrusion between PET-SO3- Na+ ion pair associations. The ionomer treated with TEOS + tetrachloroethane had more poorly formed ionic aggregates, which illustrates the influence of solvent type on ionic aggregation. First-scan DSC thermograms for the ionomers demonstrate an increase in crystallinity after the incorporation of silicates, but solvent-induced crystallization also appears to be operative. Second-scan DSC thermograms also suggest that the addition of silicate particles is not the only factor implicated in recrystallization, and that solvent type is important even in second-scan behavior. Silicate incorporation does not profoundly affect the second scan T-g vs. solvent type, i.e., chain mobility in the amorphous regions is not severely restricted by silicate incorporation. Recrystallization and melting in these hybrids appears to be due to an interplay between a solvent-induced crystallization that strongly depends on solvent type and interactions between PET chains and in situ grown, sol-gel-derived silicate particles. (C) 2002 Wiley Periodicals, Inc

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of colorectal cancer specifically as it relates to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of peritoneal mesothelioma. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of gastric cancer specifically as it relates to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of neuroendocrine tumors specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Standards

The Chicago Consensus Working Group provides the following multidisciplinary recommendations for the care of patients with peritoneal surface malignancies. This article focuses on the standards of a peritoneal surface malignancy center, standards of billing and coding, standards of operative reports for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, standards of cytoreductive surgery training, and standards of intraoperative chemotherapy preparation. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence

The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations

The Chicago Consensus Working Group provides multidisciplinary recommendations for palliative care specifically related to peritoneal surface malignancies. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence